A review of analytical techniques for determination of glimepiride: Present and perspectives

Therapeutic Drug Monitoring

Volumn 32, Issue 5, 2010, Pages 550-559

  Bonfilio, Rudy ^a   De Araújo, Magali Benjamim ^b   Salgado, Hérida Regina Nunes ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

analytical methods; biologic samples; glimepiride; pharmaceuticals; type 2 diabetes

Indexed keywords

ACETOHEXAMIDE; CARBUTAMIDE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIBORNURIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; GLIQUIDONE; GLISOXEPIDE; HERBACEOUS AGENT; INSULIN; METFORMIN; PILOCARPINE; PIOGLITAZONE; PROPRANOLOL; REPAGLINIDE; TOLAZAMIDE; TOLBUTAMIDE;

ACCURACY; AEROSOL; ANALYTIC METHOD; CLINICAL TRIAL; DRUG DETERMINATION; DRUG ISOLATION; DRUG PURITY; DRUG QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIGHT SCATTERING; MASS SPECTROMETRY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; MULTICENTER STUDY; POLAROGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SPECTROPHOTOMETRY; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; DOSAGE FORMS; DRUG COMBINATIONS; HUMANS; HYPOGLYCEMIC AGENTS; LIGHT; MASS SPECTROMETRY; POLAROGRAPHY; SCATTERING, RADIATION; SPECTROPHOTOMETRY; SULFONYLUREA COMPOUNDS;

EID: 77957287513     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181eea55a     Document Type: Review

References (55)

1. Johnson EL, Brosseau JD, Soule M, et al. Treatment of diabetes in long-term care facilities: a primary care approach. Clin Diabetes. 2008;26:152-156.
2. Cheng AYY, Leiter LA. Diabetes and cardiovascular disease: the role of glycemic control. Curr Diabetes Rep. 2009;9:65-72.
3. Fowler MJ. Diabetes treatment, part 2: oral agents for glycemic management. Clin Diabetes. 2007;25:131-134.
4. Matthews DR, Wallace TM. Sulphonylureas and the rise and fall of betacell function. Br J Diabetes Vasc Dis. 2005;5:192-196.
5. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the P cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
6. Davis SN, Granner DK.Insulin, oral hypogliceimic agents, and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman''s, the Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill, 2001:1701-1704.
7. Massi-Benedetti M. Glimerpiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience. Clin Ther. 2003;25:799-816.
8. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
9. Lai, MW, Klein-Schwartz W, Rodgers GC Jr, et al. 2005 Annual report of the American Association of Poison Control Centers National Poisoning and Exposure Database. Clin Tox. 2006; 44:803-932.
10. Fleseriu M, Skugor M, Chinnappa P, et al. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide. Endocr Pract. 2006;12:635-640.
11. Kudo K, Ishida T, Hikiji W, et al. Pattern of poisoning in Japan: selection of drugs and poisons for systematic toxicological analysis. Forensic Toxicol. 2010;28:25-32.
12. Robkamp R, Wernicke-Panten K, Draeger E. Clinical profile of the novel sulphonylurea glimepiride. Diabetes Res Clin Pract. 1996;3:S33-S42.
13. Hydrie MZI, Gul A, Ahmadani RHMY, et al. Glimepiride study on type-2 diabetic subjects. Pak J Med Sci. 2006;22:132-135.
14. Muller G, Satoh Y, Geise K. Extrapancreatic effects of sulfonylureas- a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract. 1995;28:115-137.
15. Muller G. The molecular mechanism of the insulin mimetic/sensitizing activity of the antidiabetic sulfonylurea drug amaryl. Mol Med. 2000;6: 907-933.
16. Reddy VS, Sahay RK, Bhadada SK, et al. Newer oral antidiabetic agents. Indian Acad Clin Med. 2000;1:245-251.
17. FDA - Food Drug and Administration. Center for drug evaluation and research Electronic Orange Book Query web site.. Available at: www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction= Search.Label-ApprovalHistory. Accessed March 14, 2010.
18. Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity and treatment. Ann Emerg Med. 2001;38:68-78.
19. Lehr KH, Damm P. Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by highperformance liquid chromatography after pre-column derivatization. J Chromatogr. 1990;26:497-505.
20. Altinöz S, Tekeli D. Analysis of glimepiride by using derivative UV spectrophotometric method. J Pharm Biomed Anal. 2001;24: 507-515.
21. Frick A, Mö ller H, Wirbitzki E. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. Eur J Pharm Biopharm. 1998;46:305-311.
22. Bansal G, Singh M, Jindal KC, et al. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride. J Pharm Biomed Anal. 2008;48:788-795.
23. European Pharmacopoeia, 6th ed. Strasbourg: Council of Europe; 2008.
24. United States Pharmacopeia, 30th ed. Rockville, MD: The US Pharmacopeial Convention; 2006.
25. Maurer HH, Kratzsch C, Kraemer T, et al. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. J Chromatogr B. 2002;773: 63-73. (Pubitemid 34518271)
26. Kim H, Chang KY, Lee HJ, et al. Determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Bull Korean Chem Soc 2004;25:109-114.
27. Kim H, Chang KY, Park CK, et al. Determination of glimepiride in human plasma by LC-MS-MS and comparison of sample preparation methods for glimepiride. Chromatogr 2004;60:93-98.
28. Salem II, Idrees J, Al Tamimi JI. Determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B. 2004;799:103-109. (Pubitemid 37500868)
29. Dotsikas Y, Kousoulos C, Tsatsou G, et al. Development of a rapid method for the determination of glimepiride in human plasma using liquid-liquid extraction based on 96-well format micro-tubes and liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005;19:2055-2061. (Pubitemid 41026430)
30. Pistos C, Koutsopoulou M, Panderi I. Improved liquid chromatographic tandem mass spectrometric determination and pharmacokinetic study of glimepiride in human plasma. Biomed Chromatogr. 2005;19:394-401.
31. Hoizey G, Lamiable D, Trenque T, et al. Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography- ion-trap tandem mass spectrometry and library searching. Clin Chem. 2005;51:1666-1672.
32. Yüzüak N,Ö zden T, Eren, S, et al. Determination of glimepiride in human plasma by LC-MS-MS. Chromatogr. 2007;66:S165-S168. (Pubitemid 47437249)
33. Chakradhar L, Kallem R, Karthik A, et al. A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study. Biomed Chromatogr. 2008;22:58-63.
34. Sengupta P, Bhaumik U, Ghosh A, et al. LC-MS-MS development and validation for simultaneous quantitation of metformin, glimepiride and pioglitazone in human plasma and its application to a bioequivalence study. Chromatogr. 2009;69:1243-1250.
35. Song YK, Maeng JE, Hwang HR, et al. Determination of glimepiride in human plasma using semi-microbore high performance liquid chromatography with column-switching. J Chromatogr B. 2004;810:143-149.
36. Nüñez M, Ferguson JE, Machacek D, et al. Detection of hypoglycemic drugs in human urine using micellar electrokinetic chromatography. Anal Chem. 1995;67:3668-3675.
37. Maier V, Znaleziona J, Jirovsky D, et al. Determination of antihyperglycemic drugs in nanomolar concentration levels by micellar electrokinetic chromatography with non-ionic surfactant. J Chromatogr A. 2009;1216:4492-4498.
38. Khan IU, Aslam F, Ashfaq M, et al. Determination of glimepiride in pharmaceutical formulations using HPLC and first-derivative spectrophotometric methods. J Anal Chem. 2009;64:171-175.
39. Goyal A, Singhvi I. Simultaneous spectrophotometric estimation of rosiglitazone maleate and glimepiride in tablet dosage forms. Indian J Pharm Sci. 2007;69:780-783.
40. Lakshmi KS, Rajesh T, Sharma S, et al. Development and validation of liquid chromatographic and UV derivative spectrophotometric methods for the determination of metformin, pioglitazone and glimepiride in pharmaceutical formulations. Der Pharma Chem. 2009;1:238-246.
41. Ma HL, Xu MT, Qu P, et al. Polarographic behavior and determination of glimepiride. Yaoxue Xuebao. 2005;40:750-753.
42. Patel JR, Suhagia BN, Patel MM. Simultaneous estimation of glimepiride and pioglitazone in bulk and in pharmaceutical formulation by HPTLC method. Asian J Chem. 2006;18:2873-2878.
43. KovařÌková P, Klimeš J, Dohnal J, et al. HPLC study of glimepiride under hydrolytic stress conditions. J Pharm Biomed Anal. 2004;36:205-209.
44. Sane RT, Menon SN, Inamdar S, et al. Simultaneous determination of pioglitazone and glimepiride by high-performance liquid chromatography. Chromatogr. 2004;59:451-453. (Pubitemid 38626523)
45. Kolte BL, Raut BB, Deo AA, et al. Simultaneous determination of metformin and glimepride in pharmaceutical dosage form by reversephase liquid chromatography. J Sep Sci. 2008;28:2076-2079.
46. Pathare DB, Jadhav AS, Shingare, MS. RP-LC determination of the cisisomer of glimepiride in a bulk drug substance. Chromatogr. 2007;66: 639-641.
47. Pawar SP, Meshram GA, Phadke MU. Simultaneous LC estimation of glimepiride and metformin in glimepiride immediate release and metformin sustained release tablets. Chromatogr. 2008;68:1063-1066.
48. Khan MA, Sinha S, Vartak S, et al. LC determination of glimepiride and its related impurities. J Pharm Biomed Anal. 2005;39:928-943.
49. Jain D, Jain S, Jain D, et al. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation. J Chromatogr Sci. 2008;46:501-504.
50. Karthik A, Subramanian G, Rao CM, et al. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. Pak J Pharm Sci. 2008;21:421-425.
51. Yao J, Shi YQ, Li ZR, et al. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. J Chromatogr B. 2007;853:254-259.
52. Deeb SE, Preu L, Wätzig H. Evaluation of monolithic HPLC columns for various pharmaceutical separations:method transfer from conventional phases and batch to batch repeatability. J Pharm Biomed Anal. 2007;44:85-95.
53. Bogusz MJ, Hassan H, Al-Enazi E, et al. Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies. J Pharm Biomed Anal. 2006;41:554-564.
54. Shaodong J, Lee WJ, Ee JW, et al. Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs. J Pharm Biomed Anal. 2010;51:973-978.
55. Shukla UA. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients. Ann Pharmacother. 2004;38:30-35.